159 related articles for article (PubMed ID: 22363145)
1. Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis.
He W; Li K; Wang F; Qin YR; Fan QX
World J Gastroenterol; 2012 Feb; 18(7):712-9. PubMed ID: 22363145
[TBL] [Abstract][Full Text] [Related]
2. Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis.
He W; Wang Z; Wang Q; Fan Q; Shou C; Wang J; Giercksky KE; Nesland JM; Suo Z
BMC Cancer; 2009 Dec; 9():426. PubMed ID: 19995427
[TBL] [Abstract][Full Text] [Related]
3. Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma.
Wang Q; He W; Lu C; Wang Z; Wang J; Giercksky KE; Nesland JM; Suo Z
Anticancer Res; 2009 Apr; 29(4):1233-41. PubMed ID: 19414369
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of Oct4 in different histological subtypes of esophageal squamous cell carcinomas in different clinical conditions.
Vaiphei K; Sinha SK; Kochhar R
Asian Pac J Cancer Prev; 2014; 15(8):3519-24. PubMed ID: 24870750
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of Oct4 in human esophageal squamous cell carcinoma.
Zhou X; Huang GR; Hu P
Mol Cells; 2011 Jul; 32(1):39-45. PubMed ID: 21547540
[TBL] [Abstract][Full Text] [Related]
6. XAF1 is frequently methylated in human esophageal cancer.
Chen XY; He QY; Guo MZ
World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
[TBL] [Abstract][Full Text] [Related]
7. OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma.
Li C; Yan Y; Ji W; Bao L; Qian H; Chen L; Wu M; Chen H; Li Z; Su C
PLoS One; 2012; 7(11):e49693. PubMed ID: 23185410
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Nakahara Y; Yamasaki M; Sawada G; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mimori K; Mori M; Doki Y
Oncology; 2016; 90(6):347-55. PubMed ID: 27082627
[TBL] [Abstract][Full Text] [Related]
10. Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30.
Izadpanah MH; Abbaszadegan MR; Fahim Y; Forghanifard MM
Cell Mol Biol Lett; 2017; 22():33. PubMed ID: 29299035
[TBL] [Abstract][Full Text] [Related]
11. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Yang Z; Cui Y; Ni W; Kim S; Xuan Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
[TBL] [Abstract][Full Text] [Related]
12. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
13. The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Chuangui C; Peng T; Zhentao Y
Pathol Oncol Res; 2012 Oct; 18(4):1021-7. PubMed ID: 22544356
[TBL] [Abstract][Full Text] [Related]
14. Transient Receptor Potential Melastatin 7 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma.
Nakashima S; Shiozaki A; Ichikawa D; Hikami S; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Otsuji E
Anticancer Res; 2017 Mar; 37(3):1161-1167. PubMed ID: 28314277
[TBL] [Abstract][Full Text] [Related]
15. Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma.
Shirakawa M; Fujiwara Y; Sugita Y; Moon JH; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Mori M; Doki Y
Oncol Rep; 2012 Apr; 27(4):940-6. PubMed ID: 22200953
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of uc.189 in patients with esophageal squamous cell carcinoma and its clinicopathologic value.
Guo Y; Wang C; Miao X; Chen S; Qian Y; Li G; Jiang Y
Pathol Res Pract; 2017 Nov; 213(11):1400-1403. PubMed ID: 28941722
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration.
Zhao Y; Li C; Huang L; Niu S; Lu Q; Gong D; Huang S; Yuan Y; Chen H
Cancer Med; 2018 Aug; 7(8):3977-3987. PubMed ID: 29974668
[TBL] [Abstract][Full Text] [Related]
18. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
[TBL] [Abstract][Full Text] [Related]
19. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma].
Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814
[TBL] [Abstract][Full Text] [Related]
20. Connective tissue growth factor expression in precancerous lesions of human esophageal epithelium and prognostic significance in esophageal squamous cell carcinoma.
Li LY; Li EM; Wu ZY; Huang X; Shen JH; Xu XE; Wu JY; Huang Q; Xu LY
Dis Esophagus; 2011 Jul; 24(5):337-45. PubMed ID: 21143696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
